Vitafoods Europe 2027: let’s meet up in Barcelona
Starting a project
Main en gants bleus tenant une boîte de Petri
Expertise & ingredients

Microbiota and probiotics: command of the living, from strain to finished product

From strains to your finished product.

From strain selection through to your finished product, PiLeJe CDMO draws on 30 years of experience in probiotics. A probiotic is a living organism: our whole craft consists in preserving its viability, from the strain through to the date of minimum durability of the final food supplement. 

Integrated probiotic expertise, from strain to finished product

Our approach covers every strategic stage of your development. 

Analyse en laboratoire d'une culturel microbiologique

1 – Sourcing and characterisation

Rigorous selection, precise genomic identification and characterisation of probiotic strains.

image

2 – Formulation and dosage form

espoke formulations matched to your health objectives and your target population (capsules, single-layer or bilayer tablets, sachets). 

image

3 - Technical transfer

Securing the scale-up and the move to large-scale production, in our high-technology plant.

image

4 - Packaging

Packaging plays an essential role, protecting the actives from interactions with an environment that can prove damaging. 

image

5 – Release and stability

Analytical monitoring of bacterial viability, with strict controls. 

Rigorous strain selection for a targeted approach

Our collection, enriched year after year, brings together more than 40 characterised and genetically identified strains across 15 species. We secure the quality and the safety of the microorganisms that go into your products. 

Petri avec milieu de culture bactérien

Safety and traceability

The strains selected are safe for human consumption and appear on the QPS (Qualified Presumption of Safety) list drawn up by EFSA.

Plaque 96 puits colorimétrique transparent

In vitro substantiation

The potential of a strain can be assessed through specific tests: resistance to digestive conditions (gastroduodenal environment), adhesion to mucous membranes, antimicrobial or immunomodulatory properties.

image

Preserving strain viability, through to the consumer

A probiotic is not an active like any other: it is a living organism, and it has to be preserved through to the final food supplement. Our plant adjusts every production parameter to rule out the factors that cause degradation. 

  • 18 °C / 30% RH: sensitive strains handled and processed in dedicated production areas, under strictly controlled temperature and relative humidity.
  • Over-dried excipients: bulking agents chosen to maintain a minimal water activity (Aw), essential to an optimal bacterial survival rate.
  • Systematic viability testing: the viability of the cultures is verified by enumeration on every batch of finished product, before release.

Dosage form engineering matched to living strains

To build value into your products, our teams design high-performance dosage forms, sized to the demands of living strains. 

Gouttes dorées flottantes sur fond blanc

Complex combinations

ulti-strain formulation, or synergy between probiotics and complementary actives (vitamins, minerals, plant extracts).

Comprimé bi-colore rose et blanc

Matrix engineering

Bilayer tablets to isolate incompatible ingredients or to sequence their release, gastro-resistant capsules to protect the microorganisms from gastric acidity.

High-precision French manufacturing to secure your supply flows

Your trials and your industrial production take place in the same location, with no transfer and no interruption. PiLeJe CDMO secures your supply chain in this way, with evidence-based guarantees. 

image

Supplier compliance made easier

ur group is B Corp certified and committed to a decarbonisation pathway validated by the SBTi (Scopes 1, 2 and 3).

image

A high-performance site

All your microbiome supplements are manufactured in France, at our Saint-Bonnet-de-Rochefort site, certified to the FSSC 22000 standard and operating in accordance with the requirements of the FDA 21 CFR Part 111 framework, with an annual audit carried out by independent third parties.

Main en gants bleus tenant une boîte de Petri

Let us build your probiotic solution together

Enter your technical specifications in our project qualification form. Your requirements go straight to our R&D teams, who will then get back to you. 

FAQ

What is the manufacturing lead time for a bespoke probiotic formulation?

Once the dosage form has been validated and the pilot trials completed, the average lead time for large-scale manufacturing of a probiotic supplement is around 3 to 4 months, between the firm order and delivery of the batches. This cycle secures compliance with our quality control protocols before the products are released.

How are your probiotic strains characterised?

Strain characterisation rests first on the scientific documentation provided by our suppliers, which our teams assess during the listing process: identification, safety, and the data available on the behaviour of the strain (resistance to digestive conditions, adhesion to mucous membranes, antimicrobial or immunomodulatory properties depending on the strain). On our side, we verify the genetic identity of the strains and check their viability on every batch.

Do your probiotic strains meet food safety standards?

Yes. Our entire collection of more than 40 characterised and genetically identified strains (15 species) is fully traceable. These strains are recognised as safe for human consumption and listed on the QPS (Qualified Presumption of Safety) list drawn up by EFSA. Their blending is centralised at our Saint-Bonnet-de-Rochefort site, certified to the FSSC 22000 standard and operating in accordance with the requirements of the FDA 21 CFR Part 111 framework.

Can your probiotic formulations be sold as dietary supplements in the US?

Yes. We manufacture probiotic formulations for brands targeting markets outside the EU, including dietary supplements intended for the US, where the CFU count declared on the Supplement Facts panel must hold through to the end of shelf life. That is precisely what our production conditions and our batch-by-batch viability checks are built for. One point to keep in mind: the QPS list is an EFSA framework, and strain status is assessed differently in the US. Confirming the status of each strain for the target market, and handling any filings it requires, remains the responsibility of the brand owner. We supply the technical documentation on our strains and processes to support that work.